CHIN JUNG JIEN CHANG: Open Payments
NPI 1629518246 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 10 payments from 8 companies in 2025. Trend: 2023 $155 · 2024 $143 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $55 |
| Lilly USA, LLC | 2 | $48 |
| Genentech USA, Inc. | 1 | $31 |
| ViiV Healthcare Company | 1 | $28 |
| UCB, Inc. | 1 | $27 |
| SANOFI PASTEUR INC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
Products named: BEXSERO, MOUNJARO, Actemra, DOVATO, Bimzelx, FLUZONE HIGH-DOSE, Ozempic, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
